Dow Jones Top Company Headlines at 1 PM ET: Novo Nordisk Cuts Prices for Obesity Drugs | Deutsche ... The Denmark-based company slashed prices for the first two monthly doses of Wegovy and Ozempic for ...

Novo Nordisk offers Ozempic Wegovy sold 199 per month for new self-paying patients from Nov. 17 to March 31 with discounted initial doses.

Novo Holdings will sell its stake of around 7.8% in medical-device maker Convatec.

Novo Nordisk said on Monday it would lower the U.S. price of its injectable Wegovy obesity drug and pledged to go "all in" on ...

The drugs have become popular for their significant weight-loss effects, but their high cost has made them inaccessible for ...

Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prepares for a stronger ...

Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will remain ...

A conservative group led by Mike Pence allies opposes Trump's Most-Favored-Nation drug pricing agreements with Eli Lilly and ...

New cash-paying patients can now access Wegovy/Ozempic for $199 a month. Here's what that means for Novo Nordisk stock.

Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.

Novo Holdings, which controls obesity drugmaker Novo Nordisk , will sell 154.5 million shares, or 7.8% of its stake, in ...

Novo Nordisk is lowering the price it charges customers who pay out-of-pocket for the weight loss drugs. Mr. Funk was the ...